Alvotech Ordinary Shares (ALVO) is a publicly traded Healthcare sector company. As of September 20, 2026, ALVO trades at $5.92 with a market cap of $2.09B and a P/E ratio of 0.00. ALVO moved +9.93% today. Year to date, ALVO is +14.43%; over the trailing twelve months it is -24.94%. Its 52-week range spans $2.94 to $13.08. Analyst consensus is buy with an average price target of $5.67. Rallies surfaces ALVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ALVO news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $5.92 |
| Market Cap | $2.09B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.08 |
| 52-Week Low | $2.94 |
| Volume | 2.84M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ALVO: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.67.